JAL successfully renews CEIV pharma certification
Japan Airlines Co., Ltd. (JAL) has successfully renewed its CEIV Pharma certification (Center of Excellence for Independent Validators in Pharmaceutical Logistics) at Narita Airport on October 24, 2025, following the audit conducted by IATA that began on October 23.
Since initially obtaining the CEIV Pharma certification in 2023, JAL has continuously enhanced its quality management and handling systems for pharmaceutical cargo to ensure the safe and reliable transport of medicines. In recent years, global demand for the transportation of pharmaceuticals such as vaccines, biopharmaceuticals, and regenerative medicine cell products has been increasing. Particularly, with the growing importance of high-quality temperature-controlled transport, JAL is addressing these diversifying transportation needs.
In response to growing demand and market needs, JAL launched Japan’s first GDP-compliant inter-airport trucking service in 2024, connecting Haneda, Narita, and Kansai — Japan’s three major airports. This latest renewal expanded the certification scope to include these ground transportation services, making JAL the first airline in Japan certified for both air and ground transportation in pharmaceutical logistics.
JAL aims to contribute to the well-being of people worldwide by further enhancing its safe and reliable pharmaceutical logistics services that meet the expectations of medical institutions and patients.